公司简介（英文）(Company Introduction)
Heilongjiang Fanglin Pharmaceutical Co., Ltd. was established on September 15, 2022. As a state-owned enterprise under the Longjiang Forest Industry Group, its fixed assets investment reached 140 million yuan. The company covers an area of 72,000 square meters with a building area of 52,000 square meters. It is a large-scale modern pharmaceutical enterprise integrating the processing of fresh medicinal herbs, production of traditional Chinese herbal decoctions, extraction of Chinese medicine, and research, development, and sales of health food products.
The company has established a quality control center that meets GMP standards, equipped with advanced laboratories such as microbiology and chromatography rooms, as well as comprehensive precision testing equipment including gas chromatographs, liquid chromatographs, and triple quadrupole gas chromatography-mass spectrometry systems. This enables full-process quality control from raw material procurement to finished product delivery.
|
